BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16014548)

  • 1. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
    Bencimon C; Salles G; Moreira A; Guyomard S; Coiffier B; Bienvenu J; Fabien N
    Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
    Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
    Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
    Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
    Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma.
    Guyomard S; Salles G; Coudurier M; Rousset H; Coiffier B; Bienvenu J; Fabien N
    Br J Haematol; 2003 Oct; 123(1):90-9. PubMed ID: 14510947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma.
    Erlanson M; Casiano CA; Tan EM; Lindh J; Roos G; Landberg G
    Mod Pathol; 1999 Jan; 12(1):69-74. PubMed ID: 9950165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer.
    Atalay C; Atalay G; Yilmaz KB; Altinok M
    Neoplasma; 2005; 52(1):32-5. PubMed ID: 15739023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
    Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
    Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F.
    Fritzler MJ; Rattner JB; Luft LM; Edworthy SM; Casiano CA; Peebles C; Mahler M
    Autoimmun Rev; 2011 Feb; 10(4):194-200. PubMed ID: 20933614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
    Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
    J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
    Bilici A; Yapici HS; Ercan S; Seker M; Ustaalioglu BB; Salman T; Orcun A; Gumus M
    J BUON; 2012; 17(3):502-7. PubMed ID: 23033289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
    Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
    Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
    Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.